Task: Answer the multiple-choice question.
Question: Which drug has a -21.729% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a COc1ccc(C2CC(=O)C3=C(C2)Nc2ncnn2C3c2ccccc2C)cc1
b CN(C)CCn1c(=S)[nH]c2ccc(Cl)cc2c1=O
Answer: b. CN(C)CCn1c(=S)[nH]c2ccc(Cl)cc2c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CN(C)CCn1c(=S)[nH]c2ccc(Cl)cc2c1=O
CN(C)CCn1c(=S)[nH]c2ccc(Cl)cc2c1=O
6-chloro-3-[2-(dimethylamino)ethyl]-2-sulfanylidene-1H-quinazolin-4-one